107 related articles for article (PubMed ID: 18382055)
1. [Molecular mechanism of reversing multi-drug resistance of K562/AO2 by puerarin].
Chen JW; Tao S; Luo R; Zhang GS; Xu YX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):216-21. PubMed ID: 18382055
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
[TBL] [Abstract][Full Text] [Related]
3. Puerarin sensitized K562/ADR cells by inhibiting NF-κB pathway and inducing autophagy.
Liu Q; Wang C; Meng Q; Wu J; Sun H; Sun P; Ma X; Huo X; Liu K
Phytother Res; 2021 Mar; 35(3):1658-1668. PubMed ID: 33141989
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Bmi-1 on Multidrug Resistance in K562/ADR Cells and Its Mechanisms].
Zhao BX; Liu SQ; Dong SC; Jing RN; Meng XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):758-766. PubMed ID: 32552933
[TBL] [Abstract][Full Text] [Related]
5. [Reversal effect of nuclear factor-κB protease inhibitor PDTC on multidrug resistance of K562/AO₂ cells and its mechanism].
Yang TT; Xue TY; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):903-8. PubMed ID: 20723297
[TBL] [Abstract][Full Text] [Related]
6. [NF-kappaB regulating expression of mdr1 gene and P-gp to reverse drug-resistance in leukemic cells].
Wang Y; Liu X; Zhang HT; Yu M; Wang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):950-4. PubMed ID: 17956668
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD
Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001
[TBL] [Abstract][Full Text] [Related]
8. [Effect of jiedu huayu recipe containing serum on the expressions of survivin and NF-kappaB of K562/A02 cell apoptosis by].
Ma WK; Li YY; Yao XM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1097-100. PubMed ID: 21910343
[TBL] [Abstract][Full Text] [Related]
9. [Effects of tetrandrine on nuclear factor-kappaB expression in leukemia multidrug-resistant cell line K562/A02].
Chen BA; Su AL; Cheng J; Zhao HH; Li GH; Wang XM
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):956-9. PubMed ID: 18782542
[TBL] [Abstract][Full Text] [Related]
10. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
11. [The effect of selectively inhibiting the nuclear factor kappaB activation on survivin expression in leukemic cells].
Chen WZ; Liu CF; Li LZ; Yin XX
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):714-6. PubMed ID: 17553314
[TBL] [Abstract][Full Text] [Related]
12. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
[TBL] [Abstract][Full Text] [Related]
13. [Reversal of multidrug resistance in leukemic cell line K562/AO2 by chlordelazine in vitro].
Chen LJ; Shen SH; Wang HM; Ye X; Jiang SY; Gao F; Li GM
Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):525-7. PubMed ID: 14746680
[TBL] [Abstract][Full Text] [Related]
14. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
[TBL] [Abstract][Full Text] [Related]
15. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
[TBL] [Abstract][Full Text] [Related]
16. [Effect of tetrandrine, toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line].
Zhao QX; Chen BA; Cheng J; Ding JH; Gao F; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):61-4. PubMed ID: 18315901
[TBL] [Abstract][Full Text] [Related]
17. Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR.
Wang YJ; Zhao HD; Zhu CF; Li J; Xie HJ; Chen YX
J Cancer; 2017; 8(6):1103-1112. PubMed ID: 28529625
[No Abstract] [Full Text] [Related]
18. [Study on effect of berbamine on multidrug resistance leukemia K562/Adr cells].
Dong QH; Zheng S; Xu RZ; Lu Q; He L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Sep; 24(9):820-2. PubMed ID: 15495829
[TBL] [Abstract][Full Text] [Related]
19. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
20. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
